首页|期刊导航|中华医学杂志(英文版)|Population diversity of cardiovascular outcome trials and real-world patients with diabetes in a Chinese tertiary hospital
中华医学杂志(英文版)2021,Vol.134Issue(11):1317-1323,7.DOI:10.1097/CM9.0000000000001407
Population diversity of cardiovascular outcome trials and real-world patients with diabetes in a Chinese tertiary hospital
Population diversity of cardiovascular outcome trials and real-world patients with diabetes in a Chinese tertiary hospital
摘要
关键词
Cardiovascular outcome trials/Empagliflozin/Indirectness of evidenceKey words
Cardiovascular outcome trials/Empagliflozin/Indirectness of evidence引用本文复制引用
Yi-Ling Zhou,Yong-Gang Zhang,Rui Zhang,You-Lian Zhou,Nan Li,Mi-Ye Wang,Hao-Ming Tian,She-Yu Li..Population diversity of cardiovascular outcome trials and real-world patients with diabetes in a Chinese tertiary hospital[J].中华医学杂志(英文版),2021,134(11):1317-1323,7.基金项目
The study was supported by grants from the Sichuan Science and Technology Program (No.2019YFH0150)and the 1.3.5 Project for Disciplines of Excellence,West China Hospital,Sichuan University (Nos.ZYGD18022 and 2020HXF011).She-Yu Li also received grants from the National Natural Science Foundation of China (No.21534008) and the Chief Scientist Office Project (No.CGA/19/10). (No.2019YFH0150)